Subsequent strategies and underlying mechanism of acquired resistance to PD-1 axis inhibitors in advanced non-small cell lung cancer.

Chin Med J (Engl) · 2024 · PMC10997279 · PMID 38494340

Europe PMC DOI

hedged sentence

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

did not reach statistical significanceP = 0.065so close (0.05 < p ≤ 0.1)

The median PFS in the I+A treatment group was 11.70 months, longer than that of the I + C group (5.37 months), however, this disparity did not reach statistical significance ( P = 0.065) [Supplementary Figure 3, http://links.lww.com/CM9/B982 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.